Impact	O
of	O
AAC	B:C0051639
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
in	O
combination	O
with	O
chromosomal	O
-	O
mediated	O
mechanisms	O
on	O
clinical	O
quinolone	O
resistance	O
in	O
Escherichia	O
coli	I:C0014834
.	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib-cr	I:C0017337
is	O
the	O
most	O
prevalent	O
plasmid	O
-	O
mediated	O
fluoroquinolone	O
(	O
fluoroquinolone	O
)	O
resistance	O
mechanism	I:C1514892
in	O
Enterobacteriaceae	O
.	O

Impact	O
of	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
in	O
combination	O
with	O
chromosomal	B:C0008633
-	O
mediated	O
mechanisms	O
on	O
clinical	O
quinolone	O
resistance	O
in	O
Escherichia	O
coli	I:C0014834
.	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib-cr	I:C0017337
is	O
the	O
most	O
prevalent	O
plasmid	O
-	O
mediated	O
fluoroquinolone	O
(	O
fluoroquinolone	O
)	O
resistance	O
mechanism	I:C1514892
in	O
Enterobacteriaceae	O
.	O

Impact	O
of	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
in	O
combination	O
with	O
chromosomal	O
-	O
mediated	O
mechanisms	O
on	O
clinical	O
quinolone	B:C0034428
resistance	O
in	O
Escherichia	O
coli	I:C0014834
.	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib-cr	I:C0017337
is	O
the	O
most	O
prevalent	O
plasmid	O
-	O
mediated	O
fluoroquinolone	O
(	O
fluoroquinolone	O
)	O
resistance	O
mechanism	I:C1514892
in	O
Enterobacteriaceae	O
.	O

Impact	O
of	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
in	O
combination	O
with	O
chromosomal	O
-	O
mediated	O
mechanisms	O
on	O
clinical	O
quinolone	O
resistance	B:C0013203
in	O
Escherichia	O
coli	I:C0014834
.	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib-cr	I:C0017337
is	O
the	O
most	O
prevalent	O
plasmid	O
-	O
mediated	O
fluoroquinolone	O
(	O
fluoroquinolone	O
)	O
resistance	O
mechanism	I:C1514892
in	O
Enterobacteriaceae	O
.	O

Impact	O
of	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
in	O
combination	O
with	O
chromosomal	O
-	O
mediated	O
mechanisms	O
on	O
clinical	O
quinolone	O
resistance	O
in	O
Escherichia	B:C0014834
coli	I:C0014834
.	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib-cr	I:C0017337
is	O
the	O
most	O
prevalent	O
plasmid	O
-	O
mediated	O
fluoroquinolone	O
(	O
fluoroquinolone	O
)	O
resistance	O
mechanism	I:C1514892
in	O
Enterobacteriaceae	O
.	O

Impact	O
of	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
in	O
combination	O
with	O
chromosomal	O
-	O
mediated	O
mechanisms	O
on	O
clinical	O
quinolone	O
resistance	O
in	O
Escherichia	O
coli	I:C0014834
.	O
aac	B:C0017337
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib-cr	I:C0017337
is	O
the	O
most	O
prevalent	O
plasmid	O
-	O
mediated	O
fluoroquinolone	O
(	O
fluoroquinolone	O
)	O
resistance	O
mechanism	I:C1514892
in	O
Enterobacteriaceae	O
.	O

Impact	O
of	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
in	O
combination	O
with	O
chromosomal	O
-	O
mediated	O
mechanisms	O
on	O
clinical	O
quinolone	O
resistance	O
in	O
Escherichia	O
coli	I:C0014834
.	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib-cr	I:C0017337
is	O
the	O
most	O
prevalent	O
plasmid	B:C0032136
-	O
mediated	O
fluoroquinolone	O
(	O
fluoroquinolone	O
)	O
resistance	O
mechanism	I:C1514892
in	O
Enterobacteriaceae	O
.	O

Impact	O
of	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
in	O
combination	O
with	O
chromosomal	O
-	O
mediated	O
mechanisms	O
on	O
clinical	O
quinolone	O
resistance	O
in	O
Escherichia	O
coli	I:C0014834
.	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib-cr	I:C0017337
is	O
the	O
most	O
prevalent	O
plasmid	O
-	O
mediated	O
fluoroquinolone	B:C0949665
(	O
fluoroquinolone	O
)	O
resistance	O
mechanism	I:C1514892
in	O
Enterobacteriaceae	O
.	O

Impact	O
of	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
in	O
combination	O
with	O
chromosomal	O
-	O
mediated	O
mechanisms	O
on	O
clinical	O
quinolone	O
resistance	O
in	O
Escherichia	O
coli	I:C0014834
.	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib-cr	I:C0017337
is	O
the	O
most	O
prevalent	O
plasmid	O
-	O
mediated	O
fluoroquinolone	O
(	O
fluoroquinolone	B:C0949665
)	O
resistance	O
mechanism	I:C1514892
in	O
Enterobacteriaceae	O
.	O

Impact	O
of	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
in	O
combination	O
with	O
chromosomal	O
-	O
mediated	O
mechanisms	O
on	O
clinical	O
quinolone	O
resistance	O
in	O
Escherichia	O
coli	I:C0014834
.	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib-cr	I:C0017337
is	O
the	O
most	O
prevalent	O
plasmid	O
-	O
mediated	O
fluoroquinolone	O
(	O
fluoroquinolone	O
)	O
resistance	B:C1514892
mechanism	I:C1514892
in	O
Enterobacteriaceae	O
.	O

Impact	O
of	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
in	O
combination	O
with	O
chromosomal	O
-	O
mediated	O
mechanisms	O
on	O
clinical	O
quinolone	O
resistance	O
in	O
Escherichia	O
coli	I:C0014834
.	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib-cr	I:C0017337
is	O
the	O
most	O
prevalent	O
plasmid	O
-	O
mediated	O
fluoroquinolone	O
(	O
fluoroquinolone	O
)	O
resistance	O
mechanism	I:C1514892
in	O
Enterobacteriaceae	B:C0014346
.	O

We	O
aimed	O
to	O
analyse	O
the	O
interplay	O
between	O
this	O
plasmid	B:C0032136
-	O
mediated	O
gene	O
and	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
mechanisms	I:C1514892
on	O
both	O
fluoroquinolone	O
resistance	O
and	O
bacterial	O
fitness	O
in	O
Escherichia	O
coli	I:C0014834
.	O

We	O
aimed	O
to	O
analyse	O
the	O
interplay	O
between	O
this	O
plasmid	O
-	O
mediated	O
gene	B:C0017337
and	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
mechanisms	I:C1514892
on	O
both	O
fluoroquinolone	O
resistance	O
and	O
bacterial	O
fitness	O
in	O
Escherichia	O
coli	I:C0014834
.	O

We	O
aimed	O
to	O
analyse	O
the	O
interplay	O
between	O
this	O
plasmid	O
-	O
mediated	O
gene	O
and	O
chromosomal	B:C0008633
-	O
mediated	O
quinolone	O
resistance	O
mechanisms	I:C1514892
on	O
both	O
fluoroquinolone	O
resistance	O
and	O
bacterial	O
fitness	O
in	O
Escherichia	O
coli	I:C0014834
.	O

We	O
aimed	O
to	O
analyse	O
the	O
interplay	O
between	O
this	O
plasmid	O
-	O
mediated	O
gene	O
and	O
chromosomal	O
-	O
mediated	O
quinolone	B:C0034428
resistance	O
mechanisms	I:C1514892
on	O
both	O
fluoroquinolone	O
resistance	O
and	O
bacterial	O
fitness	O
in	O
Escherichia	O
coli	I:C0014834
.	O

We	O
aimed	O
to	O
analyse	O
the	O
interplay	O
between	O
this	O
plasmid	O
-	O
mediated	O
gene	O
and	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	B:C1514892
mechanisms	I:C1514892
on	O
both	O
fluoroquinolone	O
resistance	O
and	O
bacterial	O
fitness	O
in	O
Escherichia	O
coli	I:C0014834
.	O

We	O
aimed	O
to	O
analyse	O
the	O
interplay	O
between	O
this	O
plasmid	O
-	O
mediated	O
gene	O
and	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
mechanisms	I:C1514892
on	O
both	O
fluoroquinolone	B:C0949665
resistance	O
and	O
bacterial	O
fitness	O
in	O
Escherichia	O
coli	I:C0014834
.	O

We	O
aimed	O
to	O
analyse	O
the	O
interplay	O
between	O
this	O
plasmid	O
-	O
mediated	O
gene	O
and	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
mechanisms	I:C1514892
on	O
both	O
fluoroquinolone	O
resistance	B:C0013203
and	O
bacterial	O
fitness	O
in	O
Escherichia	O
coli	I:C0014834
.	O

We	O
aimed	O
to	O
analyse	O
the	O
interplay	O
between	O
this	O
plasmid	O
-	O
mediated	O
gene	O
and	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
mechanisms	I:C1514892
on	O
both	O
fluoroquinolone	O
resistance	O
and	O
bacterial	B:C0004611
fitness	O
in	O
Escherichia	O
coli	I:C0014834
.	O

We	O
aimed	O
to	O
analyse	O
the	O
interplay	O
between	O
this	O
plasmid	O
-	O
mediated	O
gene	O
and	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
mechanisms	I:C1514892
on	O
both	O
fluoroquinolone	O
resistance	O
and	O
bacterial	O
fitness	B:C2717776
in	O
Escherichia	O
coli	I:C0014834
.	O

We	O
aimed	O
to	O
analyse	O
the	O
interplay	O
between	O
this	O
plasmid	O
-	O
mediated	O
gene	O
and	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
mechanisms	I:C1514892
on	O
both	O
fluoroquinolone	O
resistance	O
and	O
bacterial	O
fitness	O
in	O
Escherichia	B:C0014834
coli	I:C0014834
.	O

E.	B:C0014834
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
modifications	O
(	O
Ser83	O
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	O
,	O
Ser80	O
Arg	I:C0026882
in	O
ParC	O
and	O
/	O
or	O
a	O
marR	O
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	O
with	O
a	O
pBK	O
-	I:C0032136
CMV	I:C0032136
vector	O
encoding	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

E.	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	B:C0008633
-	O
mediated	O
quinolone	O
resistance	O
modifications	O
(	O
Ser83	O
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	O
,	O
Ser80	O
Arg	I:C0026882
in	O
ParC	O
and	O
/	O
or	O
a	O
marR	O
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	O
with	O
a	O
pBK	O
-	I:C0032136
CMV	I:C0032136
vector	O
encoding	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

E.	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	O
-	O
mediated	O
quinolone	B:C0034428
resistance	O
modifications	O
(	O
Ser83	O
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	O
,	O
Ser80	O
Arg	I:C0026882
in	O
ParC	O
and	O
/	O
or	O
a	O
marR	O
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	O
with	O
a	O
pBK	O
-	I:C0032136
CMV	I:C0032136
vector	O
encoding	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

E.	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	B:C0013203
modifications	O
(	O
Ser83	O
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	O
,	O
Ser80	O
Arg	I:C0026882
in	O
ParC	O
and	O
/	O
or	O
a	O
marR	O
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	O
with	O
a	O
pBK	O
-	I:C0032136
CMV	I:C0032136
vector	O
encoding	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

E.	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
modifications	B:C4277689
(	O
Ser83	O
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	O
,	O
Ser80	O
Arg	I:C0026882
in	O
ParC	O
and	O
/	O
or	O
a	O
marR	O
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	O
with	O
a	O
pBK	O
-	I:C0032136
CMV	I:C0032136
vector	O
encoding	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

E.	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
modifications	O
(	O
Ser83	B:C0026882
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	O
,	O
Ser80	O
Arg	I:C0026882
in	O
ParC	O
and	O
/	O
or	O
a	O
marR	O
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	O
with	O
a	O
pBK	O
-	I:C0032136
CMV	I:C0032136
vector	O
encoding	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

E.	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
modifications	O
(	O
Ser83	O
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	B:C0949782
,	O
Ser80	O
Arg	I:C0026882
in	O
ParC	O
and	O
/	O
or	O
a	O
marR	O
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	O
with	O
a	O
pBK	O
-	I:C0032136
CMV	I:C0032136
vector	O
encoding	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

E.	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
modifications	O
(	O
Ser83	O
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	O
,	O
Ser80	B:C0026882
Arg	I:C0026882
in	O
ParC	O
and	O
/	O
or	O
a	O
marR	O
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	O
with	O
a	O
pBK	O
-	I:C0032136
CMV	I:C0032136
vector	O
encoding	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

E.	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
modifications	O
(	O
Ser83	O
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	O
,	O
Ser80	O
Arg	I:C0026882
in	O
ParC	B:C0209525
and	O
/	O
or	O
a	O
marR	O
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	O
with	O
a	O
pBK	O
-	I:C0032136
CMV	I:C0032136
vector	O
encoding	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

E.	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
modifications	O
(	O
Ser83	O
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	O
,	O
Ser80	O
Arg	I:C0026882
in	O
ParC	O
and	O
/	O
or	O
a	O
marR	B:C0017260
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	O
with	O
a	O
pBK	O
-	I:C0032136
CMV	I:C0032136
vector	O
encoding	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

E.	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
modifications	O
(	O
Ser83	O
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	O
,	O
Ser80	O
Arg	I:C0026882
in	O
ParC	O
and	O
/	O
or	O
a	O
marR	O
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	B:C0206691
with	O
a	O
pBK	O
-	I:C0032136
CMV	I:C0032136
vector	O
encoding	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

E.	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
modifications	O
(	O
Ser83	O
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	O
,	O
Ser80	O
Arg	I:C0026882
in	O
ParC	O
and	O
/	O
or	O
a	O
marR	O
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	O
with	O
a	O
pBK	B:C0032136
-	I:C0032136
CMV	I:C0032136
vector	O
encoding	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

E.	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
modifications	O
(	O
Ser83	O
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	O
,	O
Ser80	O
Arg	I:C0026882
in	O
ParC	O
and	O
/	O
or	O
a	O
marR	O
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	O
with	O
a	O
pBK	O
-	I:C0032136
CMV	I:C0032136
vector	B:C0017397
encoding	O
AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

E.	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
derived	O
isogenic	O
strains	O
carrying	O
chromosomal	O
-	O
mediated	O
quinolone	O
resistance	O
modifications	O
(	O
Ser83	O
Leu	I:C0026882
-	I:C0026882
Asp87Asn	I:C0026882
in	O
GyrA	O
,	O
Ser80	O
Arg	I:C0026882
in	O
ParC	O
and	O
/	O
or	O
a	O
marR	O
gene	I:C0017260
deletion	I:C0017260
)	O
were	O
electroporated	O
with	O
a	O
pBK	O
-	I:C0032136
CMV	I:C0032136
vector	O
encoding	O
AAC	B:C0051639
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib-cr	I:C0051639
.	O

The	O
MICs	B:C1304747
of	O
FQs	O
were	O
determined	O
by	O
microdilution	O
and	O
bactericidal	O
activity	I:C0544570
was	O
determined	O
using	O
time	O
-	O
kill	O
curves	O
.	O

The	O
MICs	O
of	O
FQs	B:C0949665
were	O
determined	O
by	O
microdilution	O
and	O
bactericidal	O
activity	I:C0544570
was	O
determined	O
using	O
time	O
-	O
kill	O
curves	O
.	O

The	O
MICs	O
of	O
FQs	O
were	O
determined	O
by	O
microdilution	B:C0201207
and	O
bactericidal	O
activity	I:C0544570
was	O
determined	O
using	O
time	O
-	O
kill	O
curves	O
.	O

The	O
MICs	O
of	O
FQs	O
were	O
determined	O
by	O
microdilution	O
and	O
bactericidal	B:C0544570
activity	I:C0544570
was	O
determined	O
using	O
time	O
-	O
kill	O
curves	O
.	O

A	O
peritoneal	B:C0599779
sepsis	I:C0599779
murine	I:C0599779
model	I:C0599779
was	O
used	O
to	O
evaluate	O
the	O
in	O
vivo	I:C1515655
impact	O
.	O

A	O
peritoneal	O
sepsis	I:C0599779
murine	I:C0599779
model	I:C0599779
was	O
used	O
to	O
evaluate	O
the	O
in	B:C1515655
vivo	I:C1515655
impact	O
.	O

Bacterial	B:C0004611
fitness	O
was	O
analysed	O
using	O
growth	O
curves	O
and	O
competition	O
assays	I:C0005507
.	O

Bacterial	O
fitness	B:C2717776
was	O
analysed	O
using	O
growth	O
curves	O
and	O
competition	O
assays	I:C0005507
.	O

Bacterial	O
fitness	O
was	O
analysed	O
using	O
growth	O
curves	O
and	O
competition	B:C0005507
assays	I:C0005507
.	O

The	O
presence	O
of	O
the	O
aac	B:C0017337
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
increased	O
the	O
MICs	O
of	O
ciprofloxacin	O
and	O
norfloxacin	O
4	O
-	O
8	O
-	O
fold	O
for	O
all	O
E.	O
coli	I:C0014834
genotypes	O
,	O
independently	O
of	O
the	O
initial	O
resistance	O
level	O
.	O

The	O
presence	O
of	O
the	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
increased	O
the	O
MICs	B:C1304747
of	O
ciprofloxacin	O
and	O
norfloxacin	O
4	O
-	O
8	O
-	O
fold	O
for	O
all	O
E.	O
coli	I:C0014834
genotypes	O
,	O
independently	O
of	O
the	O
initial	O
resistance	O
level	O
.	O

The	O
presence	O
of	O
the	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
increased	O
the	O
MICs	O
of	O
ciprofloxacin	B:C0008809
and	O
norfloxacin	O
4	O
-	O
8	O
-	O
fold	O
for	O
all	O
E.	O
coli	I:C0014834
genotypes	O
,	O
independently	O
of	O
the	O
initial	O
resistance	O
level	O
.	O

The	O
presence	O
of	O
the	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
increased	O
the	O
MICs	O
of	O
ciprofloxacin	O
and	O
norfloxacin	B:C0028365
4	O
-	O
8	O
-	O
fold	O
for	O
all	O
E.	O
coli	I:C0014834
genotypes	O
,	O
independently	O
of	O
the	O
initial	O
resistance	O
level	O
.	O

The	O
presence	O
of	O
the	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
increased	O
the	O
MICs	O
of	O
ciprofloxacin	O
and	O
norfloxacin	O
4	O
-	O
8	O
-	O
fold	O
for	O
all	O
E.	B:C0014834
coli	I:C0014834
genotypes	O
,	O
independently	O
of	O
the	O
initial	O
resistance	O
level	O
.	O

The	O
presence	O
of	O
the	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
increased	O
the	O
MICs	O
of	O
ciprofloxacin	O
and	O
norfloxacin	O
4	O
-	O
8	O
-	O
fold	O
for	O
all	O
E.	O
coli	I:C0014834
genotypes	O
,	O
independently	O
of	O
the	O
initial	O
resistance	B:C0013203
level	O
.	O

Combination	O
of	O
the	O
aac	B:C0017337
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
with	O
three	O
or	O
four	O
chromosomal	O
mechanisms	O
was	O
necessary	O
to	O
reach	O
MIC	O
values	I:C1304747
above	O
the	O
susceptible	O
category	O
.	O

Combination	O
of	O
the	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
with	O
three	O
or	O
four	O
chromosomal	B:C0008633
mechanisms	O
was	O
necessary	O
to	O
reach	O
MIC	O
values	I:C1304747
above	O
the	O
susceptible	O
category	O
.	O

Combination	O
of	O
the	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
with	O
three	O
or	O
four	O
chromosomal	O
mechanisms	O
was	O
necessary	O
to	O
reach	O
MIC	B:C1304747
values	I:C1304747
above	O
the	O
susceptible	O
category	O
.	O

Killing	O
curve	O
assays	O
showed	O
a	O
clear	O
selective	O
advantage	O
for	O
survival	O
in	O
strains	O
harbouring	O
the	O
aac	B:C0017337
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
(	O
up	O
to	O
7	O
log10	O
cfu	O
/	O
mL	O
after	O
24	O
h	O
)	O
.	O

AAC	B:C0051639
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib	I:C0051639
-	I:C0051639
cr	I:C0051639
significantly	O
reduced	O
the	O
ciprofloxacin	O
efficacy	O
in	O
vivo	I:C1515655
.	O

AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib	I:C0051639
-	I:C0051639
cr	I:C0051639
significantly	O
reduced	O
the	O
ciprofloxacin	B:C0008809
efficacy	O
in	O
vivo	I:C1515655
.	O

AAC	O
(	I:C0051639
6	I:C0051639
'	I:C0051639
)	I:C0051639
-	I:C0051639
Ib	I:C0051639
-	I:C0051639
cr	I:C0051639
significantly	O
reduced	O
the	O
ciprofloxacin	O
efficacy	O
in	B:C1515655
vivo	I:C1515655
.	O

In	O
terms	O
of	O
bacterial	B:C0004611
fitness	O
cost	I:C2717776
,	O
maximal	O
OD	O
was	O
significantly	O
lower	O
for	O
all	O
strains	O
harbouring	O
the	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
,	O
independently	O
of	O
chromosomal	O
mutations	I:C0948447
associated	O
.	O

In	O
terms	O
of	O
bacterial	O
fitness	B:C2717776
cost	I:C2717776
,	O
maximal	O
OD	O
was	O
significantly	O
lower	O
for	O
all	O
strains	O
harbouring	O
the	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
,	O
independently	O
of	O
chromosomal	O
mutations	I:C0948447
associated	O
.	O

In	O
terms	O
of	O
bacterial	O
fitness	O
cost	I:C2717776
,	O
maximal	O
OD	O
was	O
significantly	O
lower	O
for	O
all	O
strains	O
harbouring	O
the	O
aac	B:C0017337
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
,	O
independently	O
of	O
chromosomal	O
mutations	I:C0948447
associated	O
.	O

In	O
terms	O
of	O
bacterial	O
fitness	O
cost	I:C2717776
,	O
maximal	O
OD	O
was	O
significantly	O
lower	O
for	O
all	O
strains	O
harbouring	O
the	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
,	O
independently	O
of	O
chromosomal	B:C0948447
mutations	I:C0948447
associated	O
.	O

The	O
aac	B:C0017337
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
,	O
in	O
spite	O
of	O
producing	O
low	O
-	O
level	O
resistance	O
by	O
itself	O
,	O
plays	O
a	O
relevant	O
role	O
in	O
acquisition	O
of	O
a	O
clinical	O
level	O
of	O
ciprofloxacin	O
and	O
norfloxacin	O
resistance	O
,	O
when	O
combined	O
with	O
three	O
or	O
four	O
chromosomal	O
mutations	I:C0948447
,	O
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

The	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
,	O
in	O
spite	O
of	O
producing	O
low	O
-	O
level	O
resistance	B:C0013203
by	O
itself	O
,	O
plays	O
a	O
relevant	O
role	O
in	O
acquisition	O
of	O
a	O
clinical	O
level	O
of	O
ciprofloxacin	O
and	O
norfloxacin	O
resistance	O
,	O
when	O
combined	O
with	O
three	O
or	O
four	O
chromosomal	O
mutations	I:C0948447
,	O
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

The	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
,	O
in	O
spite	O
of	O
producing	O
low	O
-	O
level	O
resistance	O
by	O
itself	O
,	O
plays	O
a	O
relevant	O
role	O
in	O
acquisition	O
of	O
a	O
clinical	O
level	O
of	O
ciprofloxacin	B:C0008809
and	O
norfloxacin	O
resistance	O
,	O
when	O
combined	O
with	O
three	O
or	O
four	O
chromosomal	O
mutations	I:C0948447
,	O
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

The	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
,	O
in	O
spite	O
of	O
producing	O
low	O
-	O
level	O
resistance	O
by	O
itself	O
,	O
plays	O
a	O
relevant	O
role	O
in	O
acquisition	O
of	O
a	O
clinical	O
level	O
of	O
ciprofloxacin	O
and	O
norfloxacin	B:C0028365
resistance	O
,	O
when	O
combined	O
with	O
three	O
or	O
four	O
chromosomal	O
mutations	I:C0948447
,	O
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

The	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
,	O
in	O
spite	O
of	O
producing	O
low	O
-	O
level	O
resistance	O
by	O
itself	O
,	O
plays	O
a	O
relevant	O
role	O
in	O
acquisition	O
of	O
a	O
clinical	O
level	O
of	O
ciprofloxacin	O
and	O
norfloxacin	O
resistance	B:C0013203
,	O
when	O
combined	O
with	O
three	O
or	O
four	O
chromosomal	O
mutations	I:C0948447
,	O
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

The	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
,	O
in	O
spite	O
of	O
producing	O
low	O
-	O
level	O
resistance	O
by	O
itself	O
,	O
plays	O
a	O
relevant	O
role	O
in	O
acquisition	O
of	O
a	O
clinical	O
level	O
of	O
ciprofloxacin	O
and	O
norfloxacin	O
resistance	O
,	O
when	O
combined	O
with	O
three	O
or	O
four	O
chromosomal	B:C0948447
mutations	I:C0948447
,	O
both	O
in	O
vitro	O
and	O
in	O
vivo	I:C1515655
.	O

The	O
aac	O
(	I:C0017337
6	I:C0017337
'	I:C0017337
)	I:C0017337
-	I:C0017337
Ib	I:C0017337
-	I:C0017337
cr	I:C0017337
gene	I:C0017337
,	O
in	O
spite	O
of	O
producing	O
low	O
-	O
level	O
resistance	O
by	O
itself	O
,	O
plays	O
a	O
relevant	O
role	O
in	O
acquisition	O
of	O
a	O
clinical	O
level	O
of	O
ciprofloxacin	O
and	O
norfloxacin	O
resistance	O
,	O
when	O
combined	O
with	O
three	O
or	O
four	O
chromosomal	O
mutations	I:C0948447
,	O
both	O
in	O
vitro	O
and	O
in	B:C1515655
vivo	I:C1515655
.	O

